Purchase of Own Securities

UNITED DRUG PLC

('United Drug' or 'the Company')

Purchase of Own Securities

United Drug announces that on 12 October 2011, its broker Davy purchased 2,919 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.3564 per share.

The 2,919 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 238,914,974 to 238,912,055. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

Ends 13 October 2011

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720